{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:25:31Z","timestamp":1788258331206,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"DOI":"10.3389\/fvets.2019.00296","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T06:16:15Z","timestamp":1567750575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Adverse Drug Reactions After Administration of Emodepside\/Praziquantel (Profender\u00ae) in an MDR1-Mutant Australian Shepherd Dog: Case Report"],"prefix":"10.3389","volume":"6","author":[{"given":"Daniela","family":"Gaens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Leith\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00436-002-0619-2","article-title":"Cyclooctadepsipeptides\u2013a new class of anthelmintically active compounds","volume":"88","author":"Harder","year":"2002","journal-title":"Parasitol Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pt.2012.06.005","article-title":"Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action","author":"Kr\u00fccken","year":"2012","journal-title":"Trends Parasitol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/acve-2017-0013","article-title":"A brief review on the mode of action of antinematodal drugs","volume":"67","author":"Abongwa","year":"2017","journal-title":"Acta Vet."},{"key":"B4","unstructured":"Profender: EPAR\u2013Product Information.2008"},{"key":"B5","unstructured":"Profender: EPAR\u2013Scientific Discussion.2008"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1096\/fj.00-0664fje","article-title":"Latrophilin-like receptor from the parasitic nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A","volume":"15","author":"Saeger","year":"2001","journal-title":"FASEB J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cub.2004.07.056","article-title":"Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans","volume":"14","author":"Willson","year":"2004","journal-title":"Curr Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ijpara.2007.05.006","article-title":"The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans","volume":"37","author":"Guest","year":"2007","journal-title":"Int J Parasitol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1017\/s0031182002002639","article-title":"The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum","volume":"126","author":"Willson","year":"2003","journal-title":"Parasitology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ijpara.2006.10.013","article-title":"Effects of the novel anthelmintic emodepside on the locomotion, egg-laying behaviour and development of Caenorhabditis elegans","volume":"37","author":"Bull","year":"2007","journal-title":"Int J Parasitol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pt.2013.01.001","article-title":"New advancement in anthelmintic drugs in veterinary medicine","volume":"29","author":"Epe","year":"2013","journal-title":"Trends Parasitol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jvp.12149","article-title":"Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis","volume":"38","author":"Elmsh\u00e4user","year":"2015","journal-title":"J Vet Pharmacol Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2885.2005.00692.x","article-title":"Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany","volume":"28","author":"Geyer","year":"2005","journal-title":"J Vet Pharmacol Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2377\/0023-2076-59-597","article-title":"Drug intolerance after administration of emodepside\/praziquantel (Profender) in MDR1-mutant dogs","volume":"59","author":"Elmsh\u00e4user","year":"2014","journal-title":"Kleintierpraxis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tvjl.2010.06.012","article-title":"Breed distribution of the nt230(del4) MDR1 mutation in dogs","volume":"189","author":"Gramer","year":"2011","journal-title":"Vet J."},{"key":"B16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7164\/antibiotics.48.820","article-title":"Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models","volume":"48","author":"Conder","year":"1995","journal-title":"J Antibiot."},{"key":"B17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s0924-8579(03)00219-x","article-title":"Cyclooctadepsipeptides\u2013an anthelmintically active class of compounds exhibiting a novel mode of action","volume":"22","author":"Harder","year":"2003","journal-title":"Int J. Antimicrob Agents."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s00436-005-1438-z","article-title":"Mechanisms of action of emodepside","volume":"97","author":"Harder","year":"2005","journal-title":"Parasitol Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10158-012-0133-x","article-title":"Worms take to the slo lane: a perspective on the mode of action of emodepside","volume":"12","author":"Holden-Dye","year":"2012","journal-title":"Invert Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10158-007-0057-z","article-title":"SLO, SLO, quick, quick, slow: calcium-activated potassium channels as regulators of Caenorhabditis elegans behaviour and targets for anthelmintics","volume":"7","author":"Holden-Dye","year":"2007","journal-title":"Invert Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/bs.apar.2016.02.010","article-title":"The Biochemistry of haemonchus contortus and other parasitic nematodes","volume":"93","author":"Harder","year":"2016","journal-title":"Adv Parasitol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.ijpara.2012.05.009","article-title":"Decreased emodepside sensitivity in unc-49 gamma-aminobutyric acid (GABA)-receptor-deficient Caenorhabditis elegans","volume":"42","author":"Miltsch","year":"2012","journal-title":"Int J Parasitol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7164\/antibiotics.45.692","article-title":"A new anthelmintic cyclodepsipeptide, PF1022A","volume":"45","author":"Sasaki","year":"1992","journal-title":"J Antibiot."},{"key":"B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s004360050031","article-title":"In vivo activities of the new anthelmintic depsipeptide PF 1022A","volume":"86","author":"von","year":"2000","journal-title":"Parasitol Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.bcp.2009.01.005","article-title":"Effects of the anthelmintic drug PF1022A on mammalian tissue and cells","volume":"77","author":"Dornetshuber","year":"2009","journal-title":"Biochem Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1124\/mol.111.071043","article-title":"Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in Caenorhabditis elegans","volume":"79","author":"Crisford","year":"2011","journal-title":"Mol Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0004062","DOI":"10.1371\/journal.pntd.0004062","article-title":"The cyclooctadepsipeptide anthelmintic emodepside differentially modulates nematode, insect and human calcium-activated potassium (SLO) channel alpha subunits","volume":"9","author":"Crisford","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B28","first-page":"555","article-title":"Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides","volume":"31","author":"Frohberg","year":"1981","journal-title":"Arzneimittelforschung."},{"key":"B29","unstructured":"Praziquantel: Summary Report (1)\u2013Committee for Veterinary Medicinal Products.1996"},{"key":"B30","unstructured":"Volume 9 B of The Rules Governing Medicinal Products in the European Union\u2013Guidelines onPharmacovigilanceforMedicinalProducts for Veterinary Use\u2013Version October 2011.2011"},{"key":"B31","unstructured":"Directive 2001\/82\/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Veterinary Medicinal Products.2001"},{"key":"B32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13071-019-3476-x","article-title":"Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections","volume":"12","author":"Karpstein","year":"2019","journal-title":"Parasit Vectors."},{"key":"B33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/jvim.13827","article-title":"The effect of the canine ABCB1-1Delta mutation on sedation after intravenous administration of acepromazine","volume":"30","author":"Deshpande","year":"2016","journal-title":"J Vet Intern Med."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2019.00296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T06:16:19Z","timestamp":1567750579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fvets.2019.00296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":33,"alternative-id":["10.3389\/fvets.2019.00296"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2019.00296","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"article-number":"296"}}